サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：頭頸部がん診断市場- 世界の産業規模、シェア、動向、機会、予測、2017-2027年：タイプ別、画像診断、生検、内視鏡、歯科診断、エンドユーザー別、地域別
市場調査レポート
商品コード
1228258

頭頸部がん診断市場- 世界の産業規模、シェア、動向、機会、予測、2017-2027年：タイプ別、画像診断、生検、内視鏡、歯科診断、エンドユーザー別、地域別

Head and Neck Cancer Diagnostic Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027 Segmented By Type, By Diagnostic Imaging, By Biopsy, By Endoscopy, By Dental Diagnostics, By End User, and By Region
出版日: | 発行: TechSci Research | ページ情報: 英文 115 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

頭頸部がん診断市場- 世界の産業規模、シェア、動向、機会、予測、2017-2027年：タイプ別、画像診断、生検、内視鏡、歯科診断、エンドユーザー別、地域別
出版日: 2023年03月01日
発行: TechSci Research
ページ情報: 英文 115 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

頭頸部がん診断の世界市場は、予測期間である2023～2027年に目覚ましいCAGRで成長すると予測されています。

がんなどの多くの慢性疾患にかかりやすい老年人口の増加が、頭頸部がん診断の世界市場の成長を促進しています。

がんの発生件数の増加が市場成長を促進

がんは、制御不能で異常な細胞の増殖を指し、がん性または良性の腫瘍として知られる塊を形成します。特に労働人口の間では、座りっぱなしのライフスタイルを採用することで、がんを含むさまざまな慢性疾患を引き起こしています。また、免疫力の低下により慢性疾患にかかりやすくなる高齢者の増加が、頭頸部がん診断の世界市場の成長をさらに後押ししています。米国国立生物工学情報センターの調査によると、頭頸部がんは世界で6番目に多いがんであるとされています。また、タバコの常用や過度のアルコール摂取も、消費者の頭頸部がんのリスクを高めるとされています。

画像診断機器に対する需要の高まりが市場成長を後押し

画像診断とは、医療介入のために体内を視覚的に表現し、臓器や組織の機能を視覚的に表現し、臓器の臨床分析を行う技術および手順を指します。頭頸部がんは、一般的に口、鼻、首、のどを覆う扁平上皮から発生するがんの一群を指します。これらのがんの正確な位置を検出し、転移の有無を判断するために、頭部MRI、副鼻腔CT、頭部CT、臨床分析、パノラマ歯科X線、歯科用コーンビームCT、PET/CT、胸部画像などが患者さんに行われる一般的な診断方法の一部となっています。

効果的な標的治療へのニーズの高まりが市場の成長を後押し

頭頸部がんの治療は、多くの腫瘍医にとって困難な課題です。治療の可否や選択は、がんの部位によって異なり、また患者によっても異なります。顔の構造が複雑なため、頭頸部がんの外科的治療は複雑になり、医療従事者の間では手術が治療モードとして好まれています。オンコサージェリーでは頭頸部がんの治療において、手術療法と放射線療法を併用することを好んでいます。手術後により良い結果を得るためには、がんの重症度を分析するための正確な診断が重要な役割を果たします。遺伝子治療、抗体薬物複合体、モノクローナル抗体などの標的分子療法のイントロダクションは、世界の頭頸部がん診断市場に潜在的な道を提供します。

利用可能なカスタマイズ

TechSci Researchでは、与えられた市場データをもとに、企業特有のニーズに応じたカスタマイズを提供しています。本レポートでは、以下のカスタマイズが可能です。

企業情報

  • 追加な市場企業の詳細分析およびプロファイリング（最大5社）。

目次

第1章 製品タイプ別概要

第2章 調査手法

第3章 COVID-19が頭頸部がん診断の世界市場に与える影響

第4章 顧客の声

第5章 エグゼクティブサマリー

第6章 頭頸部がん診断の世界市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別（画像診断、生検、内視鏡、歯科用診断薬）
    • エンドユーザー別（病院、専門クリニック、外来手術センター、その他）
    • 企業別（2021年）
    • 地域別
  • 製品市場マップ

第7章 北米の頭頸部がん診断市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア＆予測
    • タイプ別（画像診断、生検、内視鏡、歯科用診断薬）
    • エンドユーザー別（病院、専門クリニック、外来手術センター、その他）
    • 国別
  • 北米国別分析
    • 米国
    • メキシコ
    • カナダ

第8章 欧州の頭頸部がん診断市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別（画像診断、生検、内視鏡、歯科用診断薬）
    • エンドユーザー別（病院、専門クリニック、外来手術センター、その他）
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋地域の頭頸部がん診断市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別（画像診断、生検、内視鏡、歯科用診断薬）
    • エンドユーザー別（病院、専門クリニック、外来手術センター、その他）
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米の頭頸部がん診断市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別（画像診断、生検、内視鏡、歯科用診断薬）
    • エンドユーザー別（病院、専門クリニック、外来手術センター、その他）
    • 国別
  • 南米国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカの頭頸部がん診断市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別（画像診断、生検、内視鏡、歯科用診断薬）
    • エンドユーザー別（病院、専門クリニック、外来手術センター、その他）
    • 国別
  • MEA：国別分析
    • 南アフリカの頭頸部がん診断
    • サウジアラビアの頭頸部がん診断
    • UAEの頭頸部がん診断

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向と発展市場動向と新興国開拓

第14章 競合情勢

  • Addent Inc
  • GE Healthcare
  • Koninklijke Philips NV
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Fujifilm Holdings Corporation
  • Canon Medical system Corporation
  • Carestream Healthcare Inc.
  • Neusoft Medical Systems Co., Ltd.
  • Varian Medical Systems, Inc.

第15章 戦略的提言

目次
Product Code: 10618

The global head and neck cancer diagnostic market is expected to grow at an impressive CAGR in the forecast period, 2023-2027. The increasing geriatric population who are more prone to numerous chronic diseases such as cancer is driving the growth of the global head and neck cancer diagnostic market.

Inflating disposable income leads to increased healthcare expenditure by the people. Furthermore, the escalating demand for diagnostic imaging, advancing treatment modes, and the incorporation of novel technologies in diagnostics equipment by the market players are expected to stimulate market growth. Also, the increased adoption of sedentary lifestyles and modifications in dietary habits is giving rise to several incidences among consumers, which further contributes to the global head and neck cancer diagnostics market growth. The growing need for targeted therapies and the awareness among the people regarding the availability and effectiveness of several oncological treatment procedures are expected to influence the global head and neck cancer diagnostic market growth in the forecast period.

Increasing Incidences of Cancer Propels the Market Growth

Cancer refers to the uncontrolled and abnormal growth of cells that form a mass known as a tumor that can be cancerous or benign. The adoption of sedentary lifestyles, especially among the working population, leads to various chronic illnesses, including cancer. The growing old age population who are more prone to any chronic diseases as their immune system gets weak further supports the growth of the global head and neck cancer diagnostics market. As per a study by the National Center for Biotechnology Information, head and neck cancer is considered the sixth-most common cancer globally. Regular consumption of tobacco and excessive alcohol consumption also increases the risk of head and neck cancer in consumers.

Rise In Demand for Diagnostic Imaging Equipment Fuels the Market Growth

Diagnostic imaging refers to the technique and procedure of creating visual representations of the interior of a body for medical intervention, visual representation of the function of some organs or tissues, and clinical analysis of any organ. Head and neck cancer refers to the group of cancers that generally begins in the squamous cells that line the mouth, nose, neck, and throat. To detect the accurate location of these kinds of cancer and determine if it has spread, head MRI, CT of the sinuses, head CT, clinical analysis and panoramic dental x-ray, dental cone beam CT, PET/CT, or chest imaging are a few of the common diagnostic procedures which are performed upon the patients.

Elevating Need for Effective Targeted Treatment Boosts the Market Growth

Treatment for head and neck cancer is a challenging task for many oncologists. Treatment availability and choice depend upon the location of cancer and vary from patient to patient. Due to the facial structure's complexity, the surgical treatments for head and neck cancers become complex, with surgery being the preferred mode of treatment mode among healthcare professionals. Onco-surgeon prefers surgical therapy in combination with radiation therapy for head and neck cancer treatment. For better results after surgery, accurate diagnosis plays a significant role in analyzing the cancer severity. The introduction of targeted molecular therapy, including gene therapy, antibody-drug conjugates, and monoclonal antibodies, offers a potential avenue for the global head and neck cancer diagnostics market.

Market Segmentation

The global head and neck cancer diagnostics market is segmented into type, end user, regional distribution, and competitive landscape. Based on the type, the market is divided into diagnostic imaging, biopsy, endoscopy, and dental diagnostics. Diagnostic imaging is further divided into PET/CT, MRI, X-Ray, and others and biopsy is divided into incisional biopsy, fine needle aspiration biopsy, and HPV testing. Similarly, endoscopy is divided into pharyngoscopy, laryngoscopy, and pan endoscopy, and dental diagnostics is divided into brush biopsy, fluorescence visualization, acetic acid rinse method, and toluidine blue dye-based met. Based on the end user, the market is divided into hospitals, specialty clinics, ambulatory surgical centers, and others. The market analysis also studies the regional segmentation, divided among the North American region, the Asia-Pacific region, the European region, the South American region, and the Middle East & African region.

Market Players

Addent Inc, GE Healthcare, Koninklijke Philips NV, Shimadzu Corporation, Siemens Healthineers AG, Fujifilm Holdings Corporation, Canon Medical System Corporation, Carestream Healthcare Inc., Neusoft Medical Systems Co., Ltd., Varian Medical Systems, Inc. are the key market players leading the growth of the global head and neck cancer diagnostics market.

Report Scope

In this report, global head and neck cancer diagnostics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Head and Neck Cancer Diagnostics Market, By Type:

  • Diagnostic Imaging
    • PET/CT
    • MRI
    • X-Ray
    • Others
  • Biopsy
    • Incisional Biopsy
    • Fine Needle Aspiration Biopsy
    • HPV Testing
  • Endoscopy
    • Pharyngoscopy
    • Laryngoscopy
    • Panendoscopy
  • Dental Diagnostics
    • Brush Biopsy
    • Fluorescence Visualization
    • Acetic Acid Rinse Method
    • Toluidine Blue Dye-Based Method
    • Head and Neck Cancer Diagnostics Market, By End-User:
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

Head and Neck Cancer Diagnostics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global head and neck cancer diagnostics market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Type Overview

2. Research Methodology

3. Impact of COVID-19 on Global Head and Neck Cancer Diagnostics Market

4. Voice of Customer

5. Executive Summary

6. Global Head and Neck Cancer Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
      • 6.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
      • 6.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
      • 6.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
      • 6.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
    • 6.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
    • 6.2.3. By Company (2021)
    • 6.2.4. By Region
  • 6.3. Product Market Map

7. North America Head and Neck Cancer Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
      • 7.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
      • 7.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
      • 7.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
      • 7.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
    • 7.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Head and Neck Cancer Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End User
    • 7.3.2. Mexico Head and Neck Cancer Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End User
    • 7.3.3. Canada Head and Neck Cancer Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End User

8. Europe Head and Neck Cancer Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
      • 8.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
      • 8.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
      • 8.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
      • 8.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
    • 8.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
    • 8.2.3. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Head and Neck Cancer Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End User
    • 8.3.2. Germany Head and Neck Cancer Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End User
    • 8.3.3. United Kingdom Head and Neck Cancer Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End User
    • 8.3.4. Italy Head and Neck Cancer Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Spain Head and Neck Cancer Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End User

9. Asia-Pacific Head and Neck Cancer Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
      • 9.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
      • 9.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
      • 9.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
      • 9.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
    • 9.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
    • 9.2.3. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Head and Neck Cancer Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End User
    • 9.3.2. India Head and Neck Cancer Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Japan Head and Neck Cancer Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End User
    • 9.3.4. South Korea Head and Neck Cancer Diagnostics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By End User
    • 9.3.5. Australia Head and Neck Cancer Diagnostics Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By End User

10. South America Head and Neck Cancer Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
      • 10.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
      • 10.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
      • 10.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
      • 10.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
    • 10.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Head and Neck Cancer Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Argentina Head and Neck Cancer Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End User
    • 10.3.3. Colombia Head and Neck Cancer Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End User

11. Middle East and Africa Head and Neck Cancer Diagnostics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
      • 11.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
      • 11.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
      • 11.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
      • 11.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
    • 11.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
    • 11.2.3. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Head and Neck Cancer Diagnostics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By End User
    • 11.3.2. Saudi Arabia Head and Neck Cancer Diagnostics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By End User
    • 11.3.3. UAE Head and Neck Cancer Diagnostics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Addent Inc
  • 14.2. GE Healthcare
  • 14.3. Koninklijke Philips NV
  • 14.4. Shimadzu Corporation
  • 14.5. Siemens Healthineers AG
  • 14.6. Fujifilm Holdings Corporation
  • 14.7. Canon Medical system Corporation
  • 14.8. Carestream Healthcare Inc.
  • 14.9. Neusoft Medical Systems Co., Ltd.
  • 14.10. Varian Medical Systems, Inc.

15. Strategic Recommendations